Sponsor:
Mayo Clinic
Code:
NCT07213466
Conditions
Bipolar I Disorder
Bipolar II Disorder
Schizo Affective Disorder
Obesity
Weight Loss
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
Group Therapy Program
semaglutide
Phentermine-Topiramate
naltrexone and bupropion (combination)
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-04-07. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2026-03-11.